{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:28:23Z","timestamp":1787164103250,"version":"build-2736575974"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10495-026-02410-2","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T09:17:09Z","timestamp":1786353429000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genome-wide CRISPR screen reveals CGS-15943 induced heme-dependent cell death mediated by aryl hydrocarbon receptor in lung cancer cells"],"prefix":"10.1007","volume":"31","author":[{"given":"Bach D.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siva K.","family":"Kolluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"issue":"3","key":"2410_CR1","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/S0022-3565(25)39174-3","volume":"242","author":"G Ghai","year":"1987","unstructured":"Ghai G, Francis JE, Williams M, Dotson RA, Hopkins MF, Cote DT, Goodman FR, Zimmerman MB (1987) Pharmacological characterization of CGS 15943A: a novel nonxanthine adenosine antagonist. J Pharmacol Exp Ther. Am Soci Pharmacol Exp Ther. 242(3):784\u2013790","journal-title":"J Pharmacol Exp Ther. Am Soci Pharmacol Exp Ther."},{"issue":"2","key":"2410_CR2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0022-5347(25)00258-7","volume":"241","author":"M Williams","year":"1987","unstructured":"Williams M, Francis J, Ghai G, Braunwalder A, Psychoyos S, Stone GA, Cash WD (1987) Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist. J Pharmacol Exp Ther. Am Soci Pharmacol Exp Ther. 241(2):415\u2013420","journal-title":"J Pharmacol Exp Ther. Am Soci Pharmacol Exp Ther."},{"issue":"5","key":"2410_CR3","doi-asserted-by":"publisher","first-page":"524","DOI":"10.4161\/cbt.28018","volume":"15","author":"CE Edling","year":"2014","unstructured":"Edling CE, Selvaggi F, Ghonaim R, Maffucci T, Falasca M (2014) Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase\/Akt pathway. Cancer Biol Therap. 15(5):524\u2013532","journal-title":"Cancer Biol Therap."},{"issue":"5","key":"2410_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10495-021-01666-0","volume":"26","author":"EF O\u2019Donnell","year":"2021","unstructured":"O\u2019Donnell EF, Jang HS, Liefwalker DF, Kerkvliet NI, Kolluri SK (2021) Discovery and mechanistic characterization of a select modulator of AhR-regulated transcription (SMAhRT) with anti-cancer effects. Apoptosis 26(5):307\u2013322","journal-title":"Apoptosis"},{"issue":"7","key":"2410_CR5","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1007\/s00204-017-1981-2","volume":"91","author":"SK Kolluri","year":"2017","unstructured":"Kolluri SK, Jin UH, Safe S (2017) Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target. Arch Toxicol 91(7):2497\u20132513. https:\/\/doi.org\/10.1007\/s00204-017-1981-2","journal-title":"Arch Toxicol"},{"issue":"4","key":"2410_CR6","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3390\/biology12040526.PMID:37106727;PMCID:PMC10135996","volume":"12","author":"DJ Elson","year":"2023","unstructured":"Elson DJ, Kolluri SK (2023) Tumor-suppressive functions of the aryl hydrocarbon receptor (AhR) and AhR as a therapeutic target in cancer. Biology (Basel) 12(4):526. https:\/\/doi.org\/10.3390\/biology12040526.PMID:37106727;PMCID:PMC10135996","journal-title":"Biology (Basel)"},{"issue":"7","key":"2410_CR7","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.str.2017.05.008","volume":"25","author":"KW Schulte","year":"2017","unstructured":"Schulte KW, Green E, Wilz A, Platten M, Daumke O (2017) Structural basis for aryl hydrocarbon receptor-mediated gene activation. Structure 25(7):1025-1033.e3","journal-title":"Structure"},{"issue":"21","key":"2410_CR8","doi-asserted-by":"publisher","first-page":"5431","DOI":"10.1073\/pnas.1617035114","volume":"114","author":"SH Seok","year":"2017","unstructured":"Seok SH, Lee W, Jiang L, Molugu K, Zheng A, Li Y, Park S, Bradfield CA, Xing Y (2017) Structural hierarchy controlling dimerization and target DNA recognition in the AHR transcriptional complex. PNAS 114(21):5431\u20135436","journal-title":"PNAS"},{"issue":"2","key":"2410_CR9","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1073\/pnas.97.2.779","volume":"97","author":"Y Shimizu","year":"2000","unstructured":"Shimizu Y, Nakatsuru Y, Ichinose M, Takahashi Y, Kume H, Mimura J, Fujii-Kuriyama Y, Ishikawa T (2000) Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. PNAS 97(2):779\u2013782","journal-title":"PNAS"},{"issue":"7391","key":"2410_CR10","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, Wilson CJ, Leh\u00e1r J, Kryukov GV, Sonkin D, Reddy A, Liu M, Murray L, Berger MF, Monahan JE, Morais P, Meltzer J, Korejwa A, Jan\u00e9-Valbuena J, Mapa FA, Thibault J, Bric-Furlong E, Raman P, Shipway A, Engels IH, Cheng J, Yu GK, Yu J, Aspesi P, de Silva M, Jagtap K, Jones MD, Wang L, Hatton C, Palescandolo E, Gupta S, Mahan S, Sougnez C, Onofrio RC, Liefeld T, MacConaill L, Winckler W, Reich M, Li N, Mesirov JP, Gabriel SB, Getz G, Ardlie K, Chan V, Myer VE, Weber BL, Porter J, Warmuth M, Finan P, Harris JL, Meyerson M, Golub TR, Morrissey MP, Sellers WR, Schlegel R, Garraway LA (2012) The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483(7391):603\u2013607","journal-title":"Nature"},{"issue":"7368","key":"2410_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature10491","volume":"478","author":"CA Opitz","year":"2011","unstructured":"Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S, Schumacher T, Jestaedt L, Schrenk D, Weller M, Jugold M, Guillemin GJ, Miller CL, Lutz C, Radlwimmer B, Lehmann I, von Deimling A, Wick W, Platten M (2011) An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478(7368):197\u2013203","journal-title":"Nature"},{"issue":"29","key":"2410_CR12","doi-asserted-by":"publisher","first-page":"11342","DOI":"10.1074\/jbc.RA119.008882","volume":"294","author":"UH Jin","year":"2019","unstructured":"Jin UH, Karki K, Cheng Y, Michelhaugh SK, Mittal S, Safe S (2019) The aryl hydrocarbon receptor is a tumor suppressor\u2013like gene in glioblastoma. J Biol Chem 294(29):11342\u201311353","journal-title":"J Biol Chem"},{"issue":"12","key":"2410_CR13","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1093\/carcin\/bgt248","volume":"34","author":"M Contador-Troca","year":"2013","unstructured":"Contador-Troca M, Alvarez-Barrientos A, Barrasa E, Rico-Leo EM, Catalina-Fern\u00e1ndez I, Menacho-M\u00e1rquez M, Bustelo XR, Garc\u00eda-Borr\u00f3n JC, G\u00f3mez-Dur\u00e1n A, S\u00e1enz-Santamar\u00eda J, Fern\u00e1ndez-Salguero PM (2013) The dioxin receptor has tumor suppressor activity in melanoma growth and metastasis. Carcinogenesis 34(12):2683\u20132693","journal-title":"Carcinogenesis"},{"issue":"2","key":"2410_CR14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/carcin\/bgl179","volume":"28","author":"WA Fritz","year":"2007","unstructured":"Fritz WA, Lin TM, Cardiff RD, Peterson RE (2007) The aryl hydrocarbon receptor inhibits prostate carcinogenesis in TRAMP mice. Carcinogenesis 28(2):497\u2013505","journal-title":"Carcinogenesis"},{"issue":"1","key":"2410_CR15","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1158\/0008-5472.CAN-09-3090","volume":"70","author":"Y Fan","year":"2010","unstructured":"Fan Y, Boivin GP, Knudsen ES, Nebert DW, Xia Y, Puga A (2010) The Ah receptor has a tumor suppressor function in liver carcinogenesis. Cancer Res 70(1):212\u2013220","journal-title":"Cancer Res"},{"issue":"19","key":"2410_CR16","doi-asserted-by":"publisher","first-page":"e104319","DOI":"10.15252\/embj.2019104319","volume":"39","author":"H Han","year":"2020","unstructured":"Han H, Davidson LA, Fan YY, Goldsby JS, Yoon G, Jin UH, Wright GA, Landrock KK, Weeks BR, Wright RC, Allred CD, Jayaraman A, Ivanov I, Roper J, Safe SH, Chapkin RS (2020) Loss of aryl hydrocarbon receptor potentiates FoxM1 signaling to enhance self-renewal of colonic stem and progenitor cells. EMBO J 39(19):e104319","journal-title":"EMBO J"},{"issue":"32","key":"2410_CR17","doi-asserted-by":"publisher","first-page":"13481","DOI":"10.1073\/pnas.0902132106","volume":"106","author":"K Kawajiri","year":"2009","unstructured":"Kawajiri K, Kobayashi Y, Ohtake F, Ikuta T, Matsushima Y, Mimura J, Pettersson S, Pollenz RS, Sakaki T, Hirokawa T, Akiyama T, Kurosumi M, Poellinger L, Kato S, Fujii-Kuriyama Y (2009) Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin\/+ mice with natural ligands. PNAS 106(32):13481\u201313486","journal-title":"PNAS"},{"issue":"5","key":"2410_CR18","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1158\/1541-7786.MCR-20-0789","volume":"19","author":"H Han","year":"2021","unstructured":"Han H, Davidson LA, Hensel M, Yoon G, Landrock K, Allred C, Jayaraman A, Ivanov I, Safe SH, Chapkin RS (2021) Loss of aryl hydrocarbon receptor promotes colon tumorigenesis in Apc S580\/+; Kras G12D\/+ mice. Mol Cancer Res 19(5):771\u2013783","journal-title":"Mol Cancer Res"},{"issue":"7","key":"2410_CR19","doi-asserted-by":"publisher","first-page":"e40926","DOI":"10.1371\/journal.pone.0040926","volume":"7","author":"EF O\u2019Donnell","year":"2012","unstructured":"O\u2019Donnell EF, Kopparapu PR, Koch DC, Jang HS, Phillips JL, Tanguay RL, Kerkvliet NI, Kolluri SK (2012) The aryl hydrocarbon receptor mediates leflunomide-induced growth inhibition of melanoma cells. PLoS ONE 7(7):e40926","journal-title":"PLoS ONE"},{"issue":"10","key":"2410_CR20","doi-asserted-by":"publisher","first-page":"e13128","DOI":"10.1371\/journal.pone.0013128","volume":"5","author":"EF O\u2019Donnell","year":"2010","unstructured":"O\u2019Donnell EF, Saili KS, Koch DC, Kopparapu PR, Farrer D, Bisson WH, Mathew LK, Sengupta S, Kerkvliet NI, Tanguay RL, Kolluri SK (2010) The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptor. PLoS ONE 5(10):e13128","journal-title":"PLoS ONE"},{"issue":"50","key":"2410_CR21","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.1038\/onc.2015.55","volume":"34","author":"DC Koch","year":"2015","unstructured":"Koch DC, Jang HS, O\u2019Donnell EF, Punj S, Kopparapu PR, Bisson WH, Kerkvliet NI, Kolluri SK (2015) Anti-androgen flutamide suppresses hepatocellular carcinoma cell proliferation via the aryl hydrocarbon receptor mediated induction of transforming growth factor-\u03b21. Oncogene 34(50):6092\u20136104","journal-title":"Oncogene"},{"issue":"15","key":"2410_CR22","doi-asserted-by":"publisher","first-page":"25211","DOI":"10.18632\/oncotarget.16056","volume":"8","author":"EF O\u2019Donnell","year":"2017","unstructured":"O\u2019Donnell EF, Jang HS, Pearce M, Kerkvliet NI, Kolluri SK (2017) The aryl hydrocarbon receptor is required for induction of p21cip1\/waf1 expression and growth inhibition by SU5416 in hepatoma cells. Oncotarget 8(15):25211\u201325225","journal-title":"Oncotarget"},{"issue":"1","key":"2410_CR23","doi-asserted-by":"publisher","first-page":"e1038","DOI":"10.1038\/cddis.2013.549","volume":"5","author":"EF O\u2019Donnell","year":"2014","unstructured":"O\u2019Donnell EF, Koch DC, Bisson WH, Jang HS, Kolluri SK (2014) The aryl hydrocarbon receptor mediates raloxifene-induced apoptosis in estrogen receptor-negative hepatoma and breast cancer cells. Cell Death Dis 5(1):e1038\u2013e1038","journal-title":"Cell Death Dis"},{"issue":"4","key":"2410_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/biology6040041","volume":"6","author":"HS Jang","year":"2017","unstructured":"Jang HS, Pearce M, O\u2019Donnell EF, Nguyen BD, Truong L, Mueller MJ, Bisson WH, Kerkvliet NI, Tanguay RL, Kolluri SK (2017) Identification of a raloxifene analog that promotes ahr-mediated apoptosis in cancer cells. Biology 6(4):41","journal-title":"Biology"},{"issue":"8","key":"2410_CR25","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana NE, Shalem O, Zhang F (2014) Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods 11(8):783\u2013784","journal-title":"Nat Methods"},{"issue":"2","key":"2410_CR26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, Smith I, Tothova Z, Wilen C, Orchard R, Virgin HW, Listgarten J, Root DE (2016) Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat Biotechnol 34(2):184\u2013191","journal-title":"Nat Biotechnol"},{"issue":"6166","key":"2410_CR27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1247005","volume":"343","author":"O Shalem","year":"2014","unstructured":"Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelsen TS, Heckl D, Ebert BL, Root DE, Doench JG, Zhang F (2014) Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343(6166):84\u201387","journal-title":"Science"},{"issue":"3","key":"2410_CR28","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/s41596-018-0113-7","volume":"14","author":"B Wang","year":"2019","unstructured":"Wang B, Wang M, Zhang W, Xiao T, Chen CH, Wu A, Wu F, Traugh N, Wang X, Li Z, Mei S, Cui Y, Shi S, Lipp JJ, Hinterndorfer M, Zuber J, Brown M, Li W, Liu XS (2019) Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute. Nat Protoc 14(3):756\u2013780","journal-title":"Nat Protoc"},{"issue":"8","key":"2410_CR29","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41568-020-0262-1","volume":"20","author":"AJ Levine","year":"2020","unstructured":"Levine AJ (2020) p53: 800 million years of evolution and 40 years of discovery. Nat Rev Cancer 20(8):471\u2013480","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"2410_CR30","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, Barlev NA, Bazan NG, Bernassola F, Bertrand MJM, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Boya P, Brenner C, Campanella M, Candi E, Carmona-Gutierrez D, Cecconi F, Chan FKM, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Cohen GM, Conrad M, Cubillos-Ruiz JR, Czabotar PE, D\u2019Angiolella V, Dawson TM, Dawson VL, De Laurenzi D, De Maria R, Debatin KM, DeBerardinis RJ, Deshmukh M, Di Daniele N, Di Virgilio F, Dixit VM, Dixon SJ, Duckett CS, Dynlacht BD, El-Deiry WS, Elrod JW, Fimia GM, Fulda S, Garc\u00eda-S\u00e1ez AJ, Garg AD, Garrido C, Gavathiotis E, Golstein P, Gottlieb E, Green DR, Greene LA, Gronemeyer H, Gross A, Hajnoczky G, Hardwick JM, Harris IS, Hengartner MO, Hetz C, Ichijo H, J\u00e4\u00e4ttel\u00e4 M, Joseph B, Jost PJ, Juin PP, Kaiser WJ, Karin M, Kaufmann T, Kepp O, Kimchi A, Kitsis RN, Klionsky DJ, Knight RA, Kumar S, Lee SW, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, L\u00f3pez-Ot\u00edn C, Lowe SW, Luedde T, Lugli E, MacFarlane M, Madeo F, Malewicz M, Malorni W, Manic G, Marine JC, Martin SJ, Martinou JC, Medema JP, Mehlen P, Meier P, Melino S, Miao EA, Molkentin JD, Moll UM, Mu\u00f1oz-Pinedo C, Nagata S, Nu\u00f1ez G, Oberst A, Oren M, Overholtzer M, Pagano M, Panaretakis T, Pasparakis P, Penninger JM, Pereira DM, Pervaiz S, Peter ME, Piacentini M, Pinton P, Prehn JHM, Puthalakath H, Rabinovich GA, Rehm M, Rizzuto R, Rodrigues CMP, Rubinsztein DC, Rudel T, Ryan KM, Sayan E, Scorrano L, Shao F, Shi Y, Silke J, Simon HU, Sistigu A, Stockwell BR, Strasser A, Szabadkai G, Tait SWG, Tang D, Tavernarakis N, Thorburn A, Tsujimoto Y, Turk B, Vanden Berghe T, Vandenabeele P, Vander Heiden MG, Villunger A, Virgin HW, Vousden KH, Vucic D, Wagner EF, Walczak H, Wallach D, Wang Y, Wells JA, Wood W, Yuan J, Zakeri Z, Zhivotovsky B, Zitvogel L, Melino G, Kroemer G (2018) Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. Cell Death Differ 25(3):486\u2013541","journal-title":"Cell Death Differ"},{"issue":"5","key":"2410_CR31","doi-asserted-by":"publisher","first-page":"699","DOI":"10.4161\/cbt.7.5.5712","volume":"7","author":"H Berglind","year":"2008","unstructured":"Berglind H, Pawitan Y, Kato S, Ishioka C, Soussi T (2008) Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contamination. Cancer Biol Therap. 7(5):699\u2013708","journal-title":"Cancer Biol Therap."},{"issue":"6","key":"2410_CR32","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/humu.22556","volume":"35","author":"B Leroy","year":"2014","unstructured":"Leroy B, Girard L, Hollestelle A, Minna JD, Gazdar AF, Soussi T (2014) Analysis of TP53 mutation status in human cancer cell lines: a reassessment. Hum Mutat 35(6):756\u2013765","journal-title":"Hum Mutat"},{"issue":"5","key":"2410_CR33","doi-asserted-by":"publisher","first-page":"e63402","DOI":"10.1371\/journal.pone.0063402","volume":"8","author":"J Hooda","year":"2013","unstructured":"Hooda J, Cadinu D, Alam MM, Shah A, Cao TM, Sullivan LA, Brekken R, Zhang L (2013) Enhanced heme function and mitochondrial respiration promote the progression of lung cancer cells. PLoS ONE 8(5):e63402","journal-title":"PLoS ONE"},{"issue":"10","key":"2410_CR34","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1158\/0008-5472.CAN-18-2156","volume":"79","author":"S Sohoni","year":"2019","unstructured":"Sohoni S, Ghosh P, Wang T, Kalainayakan SP, Vidal C, Dey S, Konduri PC, Zhang L (2019) Elevated heme synthesis and uptake underpin intensified oxidative metabolism and tumorigenic functions in non-small cell lung cancer cells. Cancer Res 79(10):2511\u20132525","journal-title":"Cancer Res"},{"issue":"5-6","key":"2410_CR35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10495-021-01672-2","volume":"26","author":"AW Griffioen","year":"2021","unstructured":"Griffioen AW, Nowak-Sliwinska P (2021) A quarter century of apoptosis. Apoptosis 26(5\u20136):233\u2013234. https:\/\/doi.org\/10.1007\/s10495-021-01672-2","journal-title":"Apoptosis"},{"issue":"8","key":"2410_CR36","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1111\/febs.16683","volume":"290","author":"BD Nguyen","year":"2023","unstructured":"Nguyen BD, Stevens BL, Elson DJ, Finlay D, Gamble JT, Kopparapu PR, Tanguay RL, Buermeyer AB, Kerkvliet NI, Kolluri SK (2023) 11-Cl-BBQ, a select modulator of AhR-regulated transcription, suppresses lung cancer cell growth via activation of p53 and p27Kip1. FEBS J 290(8):2064\u20132084","journal-title":"FEBS J"},{"key":"2410_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115706","volume":"215","author":"DJ Elson","year":"2023","unstructured":"Elson DJ, Nguyen BD, Korjeff NA, Wilferd SF, Puig-Sanvicens V, Sang Jang H, Bernales S, Chakravarty S, Belmar S, Ureta G, Finlay D, Plaisier CL, Kolluri SK (2023) Suppression of Ah receptor (AhR) increases the aggressiveness of TNBC cells and 11-Cl-BBQ-activated AhR inhibits their growth. Biochem Pharmacol 215:115706. https:\/\/doi.org\/10.1016\/j.bcp.2023.115706","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"2410_CR38","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1021\/acsptsci.2c00253.PMID:37470014;PMCID:PMC10353065","volume":"6","author":"DJ Elson","year":"2023","unstructured":"Elson DJ, Nguyen BD, Bernales S, Chakravarty S, Jang HS, Korjeff NA, Zhang Y, Wilferd SF, Castro DJ, Plaisier CL, Finlay D, Oshima RG, Kolluri SK (2023) Induction of aryl hydrocarbon receptor-mediated cancer cell-selective apoptosis in triple-negative breast cancer cells by a high-affinity benzimidazoisoquinoline. ACS Pharmacol Transl Sci 6(7):1028\u20131042. https:\/\/doi.org\/10.1021\/acsptsci.2c00253.PMID:37470014;PMCID:PMC10353065","journal-title":"ACS Pharmacol Transl Sci"},{"key":"2410_CR39","doi-asserted-by":"publisher","first-page":"116896","DOI":"10.1016\/j.bcp.2025.116896","volume":"236","author":"LW Lin","year":"2025","unstructured":"Lin LW, Jang HS, Song Z, Ebrahimi A, Yang J, Nguyen BD, O\u2019Donnell EF, Hendrix DA, Maier CS, Kolluri SK (2025) Suppression of global protein synthesis and hepatocellular carcinoma cell growth by Benzimidazoisoquinoline, 4,11-Dichloro-BBQ. Biochem Pharmacol 236:116896. https:\/\/doi.org\/10.1016\/j.bcp.2025.116896","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"2410_CR40","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/pro.405","volume":"19","author":"G Layer","year":"2010","unstructured":"Layer G, Reichelt J, Jahn D, Heinz DW (2010) Structure and function of enzymes in heme biosynthesis. Protein Sci 19(6):1137\u20131161","journal-title":"Protein Sci"},{"issue":"3","key":"2410_CR41","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ymgme.2019.04.008","volume":"128","author":"JD Phillips","year":"2019","unstructured":"Phillips JD (2019) Heme biosynthesis and the porphyrias. Mol Genet Metab 128(3):164\u2013177","journal-title":"Mol Genet Metab"},{"issue":"2","key":"2410_CR42","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cmet.2006.12.009","volume":"5","author":"AL Hughes","year":"2007","unstructured":"Hughes AL, Powell DW, Bard M, Eckstein J, Barbuch R, Link AJ, Espenshade PJ (2007) Dap1\/PGRMC1 binds and regulates cytochrome P450 enzymes. Cell Metab 5(2):143\u2013149","journal-title":"Cell Metab"},{"key":"2410_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00159\/full","author":"CS Ryu","year":"2017","unstructured":"Ryu CS, Klein K, Zanger UM (2017) Membrane associated progesterone receptors: promiscuous proteins with pleiotropic functions: focus on interactions with cytochromes P450. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2017.00159\/full","journal-title":"Front Pharmacol"},{"key":"2410_CR44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pharmthera.2017.03.007","volume":"178","author":"F Li","year":"2017","unstructured":"Li F, Zhu W, Gonzalez FJ (2017) Potential role of CYP1B1 in the development and treatment of metabolic diseases. Pharmacol Ther 178:18\u201330","journal-title":"Pharmacol Ther"},{"issue":"2","key":"2410_CR45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.pharmthera.2013.01.010","volume":"138","author":"AV Pandey","year":"2013","unstructured":"Pandey AV, Fl\u00fcck CE (2013) NADPH P450 oxidoreductase: structure, function, and pathology of diseases. Pharmacol Ther 138(2):229\u2013254","journal-title":"Pharmacol Ther"},{"issue":"2","key":"2410_CR46","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.bbcan.2016.07.004","volume":"1866","author":"MA Cahill","year":"2016","unstructured":"Cahill MA, Jazayeri JA, Catalano SM, Toyokuni S, Kovacevic Z, Richardson DR (2016) The emerging role of progesterone receptor membrane component 1 (PGRMC1) in cancer biology. Biochim et Biophys Acta (BBA) - Rev Cancer 1866(2):339\u2013349","journal-title":"Biochim et Biophys Acta (BBA) - Rev Cancer"},{"issue":"1","key":"2410_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11030","volume":"7","author":"Y Kabe","year":"2016","unstructured":"Kabe Y, Nakane T, Koike I, Yamamoto T, Sugiura Y, Harada E, Sugase K, Shimamura T, Ohmura M, Muraoka K, Yamamoto A, Uchida T, Iwata S, Yamaguchi Y, Krayukhina E, Noda M, Handa H, Ishimori K, Uchiyama S, Kobayashi T, Suematsu M (2016) Haem-dependent dimerization of PGRMC1\/Sigma-2 receptor facilitates cancer proliferation and chemoresistance. Nat Commun 7(1):11030","journal-title":"Nat Commun"},{"issue":"37","key":"2410_CR48","doi-asserted-by":"publisher","first-page":"5204","DOI":"10.1021\/acs.biochem.6b00756","volume":"55","author":"RB Piel","year":"2016","unstructured":"Piel RB, Shiferaw MT, Vashisht AA, Marcero J, Praissman J, Phillips JD, Wohlschlegel JA, Medlock AE (2016) A novel role for progesterone receptor membrane component 1 (PGRMC1): a partner and regulator of ferrochelatase. Biochemistry 55(37):5204\u20135217","journal-title":"Biochemistry"},{"issue":"5","key":"2410_CR49","doi-asserted-by":"publisher","first-page":"101316","DOI":"10.1016\/j.jbc.2021.101316","volume":"297","author":"MR McGuire","year":"2021","unstructured":"McGuire MR, Mukhopadhyay D, Myers SL, Mosher EP, Brookheart RT, Kammers K, Sehgal A, Selen ES, Wolfgang MJ, Bumpus NN, Espenshade PJ (2021) Progesterone receptor membrane component 1 (PGRMC1) binds and stabilizes cytochromes P450 through a heme-independent mechanism. J Biol Chem 297(5):101316","journal-title":"J Biol Chem"},{"issue":"4","key":"2410_CR50","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41590-019-0323-3","volume":"20","author":"P Hubel","year":"2019","unstructured":"Hubel P, Urban C, Bergant V, Schneider WM, Knauer B, Stukalov A, Scaturro P, Mann A, Brunotte L, Hoffmann HH, Schoggins JW, Schwemmle M, Mann M, Rice CM, Pichlmair A (2019) A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape. Nat Immunol 20(4):493\u2013502","journal-title":"Nat Immunol"},{"issue":"5","key":"2410_CR51","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B, Stockwell BR (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5):1060\u20131072","journal-title":"Cell"},{"issue":"2","key":"2410_CR52","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gasc\u00f3n S, Hatzios SK, Kagan VE, Noel K, Jiang X, Linkermann A, Murphy ME, Overholtzer A, Oyagi A, Pagnussat GC, Park J, Ran Q, Rosenfeld CS, Salnikow K, Tang D, Torti FM, Torti SV, Toyokuni S, Woerpel KA, Zhang DD (2017) Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171(2):273\u2013285","journal-title":"Cell"},{"issue":"12","key":"2410_CR53","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41589-019-0408-1","volume":"15","author":"M Conrad","year":"2019","unstructured":"Conrad M, Pratt DA (2019) The chemical basis of ferroptosis. Nat Chem Biol 15(12):1137\u20131147","journal-title":"Nat Chem Biol"},{"issue":"3","key":"2410_CR54","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41589-020-0472-6","volume":"16","author":"Y Zou","year":"2020","unstructured":"Zou Y, Li H, Graham ET, Deik AA, Eaton JK, Wang W, Sandoval-Gomez G, Clish CB, Doench JG, Schreiber SL (2020) Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis. Nat Chem Biol 16(3):302\u2013309","journal-title":"Nat Chem Biol"},{"issue":"2","key":"2410_CR55","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molcel.2020.11.024","volume":"81","author":"B Yan","year":"2021","unstructured":"Yan B, Ai Y, Sun Q, Ma Y, Cao Y, Wang J, Zhang Z, Wang X (2021) Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1. Mol Cell 81(2):355-369.e10","journal-title":"Mol Cell"},{"issue":"7","key":"2410_CR56","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW (2012) NIH image to ImageJ: 25 years of image analysis. Nat Methods 9(7):671\u2013675","journal-title":"Nat Methods"},{"issue":"11","key":"2410_CR57","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F (2013) Genome engineering using the CRISPR-Cas9 system. Nat Protoc 8(11):2281\u20132308","journal-title":"Nat Protoc"},{"issue":"4","key":"2410_CR58","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods 25(4):402\u2013408","journal-title":"Methods"},{"key":"2410_CR59","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1471-2105-13-134","volume":"13","author":"J Ye","year":"2012","unstructured":"Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL (2012) Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinf 13:134","journal-title":"BMC Bioinf"},{"issue":"5","key":"2410_CR60","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nbt.3519","volume":"34","author":"NL Bray","year":"2016","unstructured":"Bray NL, Pimentel H, Melsted P, Pachter L (2016) Near-optimal probabilistic RNA-seq quantification. Nat Biotechnol 34(5):525\u2013527","journal-title":"Nat Biotechnol"},{"issue":"43","key":"2410_CR61","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102(43):15545\u201315550","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7269","key":"2410_CR62","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, Schinzel AC, Sandy P, Meylan E, Scholl C, Fr\u00f6hling S, Chan EM, Sos ML, Michel K, Mermel C, Silver SJ, Weir BA, Reiling JH, Sheng Q, Gupta PB, Wadlow RC, Le H, Hoersch S, Wittner BS, Ramaswamy S, Livingston DM, Sabatini DM, Meyerson M, Thomas RK, Lander ES, Mesirov JP, Root DE, Gilliland DG, Jacks T, Hahn WC (2009) Systematic RNA interference reveals that oncogenic KRAS -driven cancers require TBK1. Nature 462(7269):108\u2013112","journal-title":"Nature"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02410-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02410-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02410-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:02:34Z","timestamp":1787162554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-026-02410-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":62,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2410"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02410-2","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there are no conflicts of interest related to the work described in this manuscript.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"204"}}